Application of Genomics and Pharmacogenomics in Infectious Disease
This course discusses the potential application of genomics and pharmacogenomics in disease monitoring, treatment, and control in individuals and populations by improving diagnostic accuracy. In addition, the course discusses the use of genomic technologies such as the genome-wide association studies and next-generation sequencing in infectious diseases.
Teaching methods
• Lectures
• E-Lab
- Course CodeOPPM 304
- ModuleModule 3
- Credit Hours6ECTS/3EG/3LB
- Describe how the principles of human genetics are employed to optimize antimicrobial therapy and patient care.
- Recognize the impact of Pharmacogenomics in Antimicrobial treatment and how it improves various problems in drug therapy optimizations and patient care.
- Recognize the principles of genetic associations with susceptibility to infectious diseases.
- Describe bacterial pathogenicity and the development of antibiotics.
- Validate the use of metagenomic next-generation sequencing for diagnosing of infectious diseases.
- Examine how scientists craft an equitable and just ethical framework and a sustainable environment for effective policies.
- Investigate the genome-wide association results for the major infectious diseases.
- Examine challenges in pharmacogenomics professional practice towards infectious diseases and making relevant decisions in the light of guidelines and supplied information.
- Apply pharmacogenomics concepts to a particular antimicrobial therapy to solve relevant problems in healthcare.
- Determine the impact of genetic variation on susceptibility to infectious diseases.
- Show proficiency in applying basic pharmacogenomics and molecular genetic techniques in infectious diseases.
- Critically evaluate relevant literature with respect to pharmacogenomics in genetic testing for infectious diseases and its impact on patient care.
- Encourage the healthcare team collaboration regarding the dissemination of Pharmacogenomics concepts, patient education and collaboration between healthcare providers.